Are you Dr. Han?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 7 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
800 Spruce St
Philadelphia, PA 19107Phone+1 215-829-5933
Summary
- Dr. Yusheng Han, MD is a board certified pathologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Minnesota, and California. He is affiliated with Kaiser Permanente Roseville Medical Center and Kaiser Permanente Sacramento Medical Center.
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine Surgical PathologyFellowship, Selective Pathology, 2011 - 2012
- Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2006 - 2010
- Southeast University Medical CollegeClass of 1988
Certifications & Licensure
- CA State Medical License 2009 - 2025
- MN State Medical License 2012 - 2014
- NY State Medical License Active through 2013
- PA State Medical License 2006 - 2010
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 41 citationsDiagnostic Performance of Contrast-Enhanced MRI With Secretin-Stimulated MRCP for Non-Calcific Chronic Pancreatitis: A Comparison With Histopathology.Guru Trikudanathan, Sidney Walker, Satish Munigala, Benjamin Spilseth, Ahmad Malli
The American Journal of Gastroenterology. 2015-09-15 - 28 citationsEvaluation of Rosemont criteria for non-calcific chronic pancreatitis (NCCP) based on histopathology – A retrospective studyGuru Trikudanathan, Satish Munigala, Usman Barlass, Ahmad Malli, Yusheng Han
Pancreatology. 2017-01-01 - 60 citationsBile modulates intestinal epithelial barrier function via an extracellular signal related kinase 1/2 dependent mechanismRunkuan Yang, Tomoyuki Harada, Jinyou Li, Takashi Uchiyama, Yusheng Han
Intensive Care Medicine. 2005-03-22
Press Mentions
- Burning Rock Reports First Quarter 2021 Financial ResultsMay 25th, 2021
- IPO Launch: Burning Rock Biotech Pursues $196 Million U.S. IPOJune 8th, 2020